Complementary Medicines Australia - Consultation: Options for the future regulation of “low risk” products

Consultation: Options for the future regulation of “low risk” products

31 Mar 2017 1:08 PM | Anonymous

The Therapeutic Goods Administration is seeking comments on a set of proposed options for future regulation of ‘low risk products’.
The options presented in the consultation paper represents a range of possible regulatory directions for the identified ‘low risk’ products.

This consultation closes on 12 May 2017.
To read the Alert click here

Powered by Wild Apricot Membership Software